- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 140 Pages
Global
From €4257EUR$4,850USD£3,653GBP
- Report
- September 2022
- 117 Pages
Global
From €3950EUR$4,500USD£3,390GBP
- Report
- April 2023
- 120 Pages
Global
From €6584EUR$7,500USD£5,649GBP
Chantix (varenicline) is a prescription medication used to help people quit smoking. It is a partial agonist of the nicotinic acetylcholine receptor, which helps reduce the craving and withdrawal symptoms associated with quitting smoking. It is also used to reduce the urge to smoke in people who are not ready to quit. Chantix is part of a larger class of drugs known as Addiction Disorders Drugs, which are used to treat various forms of addiction, including alcohol, opioids, and nicotine.
Chantix is a popular choice for those looking to quit smoking, as it has been shown to be effective in helping people quit. It is also generally well-tolerated, with few side effects. However, it is important to note that Chantix is not a cure for nicotine addiction, and it is important to combine it with other forms of treatment, such as counseling and support groups.
Some companies in the Chantix market include Pfizer, GlaxoSmithKline, and Mylan. Show Less Read more